Vaccine and Immunology

Vaccine Safety, Pharmacovigilance, and Adverse Event Monitoring

Vaccine safety underpins public trust and successful immunization programs. Continuous monitoring of adverse events through pharmacovigilance, electronic reporting, and AI-driven analytics ensures timely detection and response. Clinical trials and post-marketing surveillance assess safety across diverse populations, including children, elderly, pregnant, and immunocompromised individuals. Transparent communication, risk-benefit evaluation, and public engagement mitigate hesitancy and maintain confidence. Advanced monitoring systems enable rapid signal detection, early intervention, and evidence-based policy updates, strengthening global immunization efforts.